Canindia News

India to explore blood plasma therapy for corona patients

New Delhi, April 11 (IANS) India will explore novel blood plasma therapy for COVID-19 using the immune power gained by a recovered person to treat a sick person.

Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), an Institution of National Importance under the Department of Science and Technology, has obtained the go-ahead for taking a bold step to provide innovative treatment to patients suffering from COVID-19 disease.

Technically called “convalescent-plasma therapy”, the treatment aims at using the immune power gained by a recovered person to treat a sick person.

According to a statement by Ministry of Science & Technology, the Indian council for medical research (ICMR), the top authorising body in India, has given approval to the SCTIMST for carrying out the novel treatment.

“We have applied for age cutoff to the Drug Controller General of India (DCGI) for permissions for relaxation of the norms for blood donation,” said Asha Kishore Director, SCTIMST.

The therapy, like blood transfusion, harvests the antibody from a recovered patient and ingest into a sick person. Helped by the antibody, the immune system mounts robust combat on the virus.

“Initially, we will try in a small number of patients. At present it is permitted as an experimental therapy for restricted use for severely affected patients only. We will be getting the informed consent before they are recruited. This will be conducted as a clinical trial,” said Kishore.

“COVID clinics of five medical college hospitals will be partnering,” he said.

In this procedure, blood is drawn from a person who has recovered from COVID-19 sickness. The serum is separated and screened for virus-neutralizing antibodies. Convalescent serum, that is the blood serum obtained from one who has recovered from an infectious disease and especially rich in antibodies for that pathogen, is then administered to a COVID-19 patient. The sick acquires passive immunization.

This therapy is not simple to harness, primarily due to the difficulty of obtaining significant amounts of plasma from survivors. In diseases like COVID-19, where most of the victims are aged, suffering from other medical conditions such as hypertension, diabetes, and so on, not all recovered patients can volunteer to donate blood.

–IANS

san/prs

YOU MAY ALSO BE INTERESTED IN

Kapil Dev: India cricket legend stable after heart surgery

CIEDITOR

Indian composer Atif Afzal set to make music for BBC project

CIEDITOR-TWINKLE

Eros Now issues apology for Navratri posters as #BoycottErosNow trends on Twitter

CIEDITOR-TWINKLE

Punjab to resume normal OPD services from Oct 19

Crops on 67,864 hectares of land damaged due to rains in Andhra

India’s merchandise exports rise by 6% in September

Aamir Khan on Akshay Kumar’s Laxmmi Bomb: Wish it was releasing in theatres

JLR India hopeful of festive cheer, goes for product offensive (IANS Special)

Punjab CM asks village heads to counter Covid propaganda

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

SUBSCRIBE TO OUR WEEKLY NEWSLETTER

Stay up to date with the latest news and exclusive offers directly in your inbox